This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blomqvist, S.
Right arrow Articles by Hovi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blomqvist, S.
Right arrow Articles by Hovi, T.

 Previous Article  |  Next Article 

Journal of Virology, May 2004, p. 4876-4883, Vol. 78, No. 9
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.9.4876-4883.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Characterization of a Highly Evolved Vaccine-Derived Poliovirus Type 3 Isolated from Sewage in Estonia

Soile Blomqvist,1* Carita Savolainen,1 Pia Laine,1 Päivi Hirttiö,1 Elisa Lamminsalo,1 Eija Penttilä,1 Silver Jöks,2 Merja Roivainen,1 and Tapani Hovi1

Department of Microbiology, Enterovirus Laboratory, National Public Health Institute (KTL), 00300 Helsinki, Finland,1 Central Laboratory of Virology, Health Protection Inspectorate, 11315 Tallinn, Estonia2

Received 24 September 2003/ Accepted 2 January 2004

Two types of vaccine-derived polioviruses have been recently designated to emphasize the different origins of the evolved viruses: circulating vaccine-derived polioviruses (cVDPV) associated with outbreaks of paralytic disease and strains isolated from chronically infected immunodeficient individuals (iVDPV). We describe here a type 3 VDPV (PV3/EST/02/E252; later E252) isolated from sewage collected in Tallinn, Estonia, in October 2002. Due to aberrant properties in subtyping, the virus was subjected to detailed characterization. Partial genomic sequencing suggested that the closest relative was the oral vaccine strain PV3/Sabin, but the two virus strains shared only 86.7% of the 900 nucleotides (nt) coding for the capsid protein VP1. Phylogenetic analysis of the nearly complete genome [nt 19 to poly(A)] revealed multiple nucleotide substitutions throughout the genome and a possible Sabin 3/Sabin 1-recombination junction site in the 2C coding region. A calculation based on the estimated mutation frequency of the P1 region of polioviruses suggested that the E252 virus might have replicated in one or more individuals for approximately 10 years. No persons chronically excreting poliovirus are known in Estonia. Amino acid substitutions were seen in all known antigenic sites, which was consistent with the observed aberrant antigenic properties of the virus demonstrated by both monoclonal antibodies and human sera from vaccinated children. In spite of the apparent transmission potential, no evidence was obtained for circulation of the virus in the Estonian population.


* Corresponding author. Mailing address: Department of Microbiology, Enterovirus Laboratory, National Public Health Institute (KTL), Mannerheimintie 166, 00300 Helsinki, Finland. Phone: 358 9 47448490. Fax: 358 9 47448355. E-mail: soile.blomqvist{at}ktl.fi.


Journal of Virology, May 2004, p. 4876-4883, Vol. 78, No. 9
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.9.4876-4883.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Savolainen-Kopra, C., Samoilovich, E., Kahelin, H., Hiekka, A.-K., Hovi, T., Roivainen, M. (2009). Comparison of poliovirus recombinants: accumulation of point mutations provides further advantages. J. Gen. Virol. 90: 1859-1868 [Abstract] [Full Text]  
  • Odoom, J. K., Yunus, Z., Dunn, G., Minor, P. D., Martin, J. (2008). Changes in Population Dynamics during Long-Term Evolution of Sabin Type 1 Poliovirus in an Immunodeficient Patient. J. Virol. 82: 9179-9190 [Abstract] [Full Text]  
  • Dedepsidis, E., Kyriakopoulou, Z., Pliaka, V., Kottaridi, C., Bolanaki, E., Levidiotou-Stefanou, S., Komiotis, D., Markoulatos, P. (2007). Retrospective Characterization of a Vaccine-Derived Poliovirus Type 1 Isolate from Sewage in Greece. Appl. Environ. Microbiol. 73: 6697-6704 [Abstract] [Full Text]  
  • Romanenkova, N. I., Guillot, S., Rozaeva, N. R., Crainic, R., Bichurina, M. A., Delpeyroux, F. (2006). Use of a Multiple Restriction Fragment Length Polymorphism Method for Detecting Vaccine-Derived Polioviruses in Clinical Samples. J. Clin. Microbiol. 44: 4077-4084 [Abstract] [Full Text]  
  • Yakovenko, M. L., Cherkasova, E. A., Rezapkin, G. V., Ivanova, O. E., Ivanov, A. P., Eremeeva, T. P., Baykova, O. Y., Chumakov, K. M., Agol, V. I. (2006). Antigenic Evolution of Vaccine-Derived Polioviruses: Changes in Individual Epitopes and Relative Stability of the Overall Immunological Properties. J. Virol. 80: 2641-2653 [Abstract] [Full Text]  
  • Karakasiliotis, I., Paximadi, E., Markoulatos, P. (2005). Evolution of a rare vaccine-derived multirecombinant poliovirus. J. Gen. Virol. 86: 3137-3142 [Abstract] [Full Text]  
  • Rutjes, S. A., Italiaander, R., van den Berg, H. H. J. L., Lodder, W. J., de Roda Husman, A. M. (2005). Isolation and Detection of Enterovirus RNA from Large-Volume Water Samples by Using the NucliSens miniMAG System and Real-Time Nucleic Acid Sequence-Based Amplification. Appl. Environ. Microbiol. 71: 3734-3740 [Abstract] [Full Text]  
  • Laassri, M., Dragunsky, E., Enterline, J., Eremeeva, T., Ivanova, O., Lottenbach, K., Belshe, R., Chumakov, K. (2005). Genomic Analysis of Vaccine-Derived Poliovirus Strains in Stool Specimens by Combination of Full-Length PCR and Oligonucleotide Microarray Hybridization. J. Clin. Microbiol. 43: 2886-2894 [Abstract] [Full Text]  
  • Cherkasova, E. A., Yakovenko, M. L., Rezapkin, G. V., Korotkova, E. A., Ivanova, O. E., Eremeeva, T. P., Krasnoproshina, L. I., Romanenkova, N. I., Rozaeva, N. R., Sirota, L., Agol, V. I., Chumakov, K. M. (2005). Spread of Vaccine-Derived Poliovirus from a Paralytic Case in an Immunodeficient Child: an Insight into the Natural Evolution of Oral Polio Vaccine. J. Virol. 79: 1062-1070 [Abstract] [Full Text]  
  • Martin, J., Odoom, K., Tuite, G., Dunn, G., Hopewell, N., Cooper, G., Fitzharris, C., Butler, K., Hall, W. W., Minor, P. D. (2004). Long-Term Excretion of Vaccine-Derived Poliovirus by a Healthy Child. J. Virol. 78: 13839-13847 [Abstract] [Full Text]